MDM2 and MDMX, two main negative regulators of p53, have been shown to be overexpressed in 38 and 65% of breast cancer cases, respectively [7], whereas in most cervical cancers, wtp53 is inactivated by the human papillomavirus (HPV) E6 oncoprotein [8]. The gene discussed is TP53; the disease is breast carcinoma.